Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Imprivata® (NYSE: IMPR) (the “Company”), the healthcare IT security company, today announced the completion of its acquisition by leading private equity investment firm Thoma Bravo, LLC...
Imprivata Cortext secure communications platform integrates with Nuance Dragon Medical One to make secure messaging and texting of physician orders easy through speech Imprivata®...
Imprivata PatientSecure selected to help eliminate costly duplicate patient medical records and improve patient safety with innovative positive patient identification platform Imprivata®...
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Imprivata, Inc. (NYSE:IMPR) (“Imprivata” or “the Company”) in connection with the sale of...
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by...
The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Imprivata, Inc. (“Imprivata”) (NYSE:IMPR) stock prior to July 13, 2016...
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by...
Rigrodsky & Long, P.A.: Do you own shares of Imprivata, Inc. (NYSE: IMPR)? Did you purchase any of your shares prior to July 13, 2016? Do you think the proposed buyout price...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Whether the Sale of Imprivata, Inc. to Thoma Bravo is Fair to Shareholders - IMPR PR Newswire NEW YORK, July 18, 2016...
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Imprivata, Inc. ("Imprivata” or "the Company") (NYSE: IMPR) for...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
